Amer Zeidan
Amer Zeidan/yalemedicine.com

Amer Zeidan: Yale Opens New Roles in Hematologic Malignancies

Amer Zeidan, Professor of Medicine, Chief of Hematologic Malignancies, Director of Heme Clinical Research at Yale University, shared a post on LinkedIn:

“It is an absolute pleasure to lead a world class division of Hematologic Malignancies at Yale University and Yale Comprehensive Cancer Center. We are looking for faculty focused on lymphoid malignancies, plasma cell malignancies, and cellular therapies/transplantation who are licensed to work in USA and have a proven record of academic work. We are also looking for outstanding APPs (APRNs/PAs) to join our quickly expanding group.

Please reach out to me if you want or know someone who wants to join this highly energetic, successful and collegial group.”

Amer Zeidan: Yale Opens New Roles in Hematologic Malignancies

More posts featuring Amer Zeidan.